These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Genetic mapping of the beta 1- and gamma-subunits of the human skeletal muscle L-type voltage-dependent calcium channel on chromosome 17q and exclusion as candidate genes for malignant hyperthermia susceptibility. Iles DE; Segers B; Sengers RC; Monsieurs K; Heytens L; Halsall PJ; Hopkins PM; Ellis FR; Hall-Curran JL; Stewart AD Hum Mol Genet; 1993 Jul; 2(7):863-8. PubMed ID: 8395940 [TBL] [Abstract][Full Text] [Related]
4. Exclusion of malignant hyperthermia susceptibility (MHS) from a putative MHS2 locus on chromosome 17q and of the alpha 1, beta 1, and gamma subunits of the dihydropyridine receptor calcium channel as candidates for the molecular defect. Sudbrak R; Golla A; Hogan K; Powers P; Gregg R; Du Chesne I; Lehmann-Horn F; Deufel T Hum Mol Genet; 1993 Jul; 2(7):857-62. PubMed ID: 8395939 [TBL] [Abstract][Full Text] [Related]
5. Localization of the gamma-subunit of the skeletal muscle L-type voltage-dependent calcium channel gene (CACNLG) to human chromosome band 17q24 by in situ hybridization and identification of a polymorphic repetitive DNA sequence at the gene locus. Iles DE; Segers B; Weghuis DO; Suikerbuijk R; Wieringa B Cytogenet Cell Genet; 1993; 64(3-4):227-30. PubMed ID: 8404045 [TBL] [Abstract][Full Text] [Related]
6. Localization of the gene encoding the alpha 2/delta-subunits of the L-type voltage-dependent calcium channel to chromosome 7q and analysis of the segregation of flanking markers in malignant hyperthermia susceptible families. Iles DE; Lehmann-Horn F; Scherer SW; Tsui LC; Olde Weghuis D; Suijkerbuijk RF; Heytens L; Mikala G; Schwartz A; Ellis FR Hum Mol Genet; 1994 Jun; 3(6):969-75. PubMed ID: 7951247 [TBL] [Abstract][Full Text] [Related]
7. Detection of a novel common mutation in the ryanodine receptor gene in malignant hyperthermia: implications for diagnosis and heterogeneity studies. Quane KA; Keating KE; Manning BM; Healy JM; Monsieurs K; Heffron JJ; Lehane M; Heytens L; Krivosic-Horber R; Adnet P Hum Mol Genet; 1994 Mar; 3(3):471-6. PubMed ID: 8012359 [TBL] [Abstract][Full Text] [Related]
8. A complex satellite DNA polymorphism flanking the human ryanodine receptor gene (RYR1). Wolz W; Wendelmuth U; Rouquier S; Giorgi D; Müller CR Cytogenet Cell Genet; 1996; 72(2-3):215-6. PubMed ID: 8978780 [TBL] [Abstract][Full Text] [Related]
9. [What significance to genotype changes have in diagnosis of malignant hyperthermia?]. Steinfath M; Scholz J; Singh S; Wappler F Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Aug; 31(6):334-43. PubMed ID: 8962927 [TBL] [Abstract][Full Text] [Related]
10. The gene for pancreatic polypeptide (PPY) and the anonymous marker D17S78 are within 45 kb of each other on chromosome 17q21. Chandrasekharappa SC; Friedman L; King SE; Lee YH; Welsch P; Bowcock AM; Weber BL; King MC; Collins FS Genomics; 1994 May; 21(2):458-60. PubMed ID: 8088848 [No Abstract] [Full Text] [Related]
11. Adult muscle sodium channel alpha-subunit is a gene candidate for malignant hyperthermia susceptibility. Olckers A; Meyers DA; Meyers S; Taylor EW; Fletcher JE; Rosenberg H; Isaacs H; Levitt RC Genomics; 1992 Nov; 14(3):829-31. PubMed ID: 1330893 [No Abstract] [Full Text] [Related]
12. Locations of human genes for alpha 1A, alpha 1B, and alpha 1E calcium channels determined by radiation hybrid mapping. Yamazaki K; Oki T; Tanaka I J Hered; 1998; 89(3):269-71. PubMed ID: 9656471 [TBL] [Abstract][Full Text] [Related]
13. Assignment of the human gene for the beta subunit of the voltage-dependent calcium channel (CACNLB1) to chromosome 17 using somatic cell hybrids and linkage mapping. Gregg RG; Powers PA; Hogan K Genomics; 1993 Jan; 15(1):185-7. PubMed ID: 8381767 [TBL] [Abstract][Full Text] [Related]
14. The genetics of malignant hyperthermia. Ball SP; Johnson KJ J Med Genet; 1993 Feb; 30(2):89-93. PubMed ID: 8383206 [TBL] [Abstract][Full Text] [Related]
15. A CA-repeat polymorphism near DXS418 (P122). Van De Vosse E; Booms PF; Vossen RH; Wapenaar MC; Van Ommen GJ; Den Dunnen JT Hum Mol Genet; 1993 Dec; 2(12):2202. PubMed ID: 8111402 [No Abstract] [Full Text] [Related]
16. A G-to-A single nucleotide polymorphism in intron 2 of the human CACNA2D2 gene that maps at 3p21.3. Angeloni D; Duh FM; Wei MF; Johnson BE; Lerman MI Mol Cell Probes; 2001 Apr; 15(2):125-7. PubMed ID: 11292331 [No Abstract] [Full Text] [Related]
17. Mutation screening of the RYR1 gene in malignant hyperthermia: detection of a novel Tyr to Ser mutation in a pedigree with associated central cores. Quane KA; Keating KE; Healy JM; Manning BM; Krivosic-Horber R; Krivosic I; Monnier N; Lunardi J; McCarthy TV Genomics; 1994 Sep; 23(1):236-9. PubMed ID: 7829078 [TBL] [Abstract][Full Text] [Related]
18. Exertional rhabdomyolysis and malignant hyperthermia in a patient with ryanodine receptor type 1 gene, L-type calcium channel alpha-1 subunit gene, and calsequestrin-1 gene polymorphisms. Capacchione JF; Sambuughin N; Bina S; Mulligan LP; Lawson TD; Muldoon SM Anesthesiology; 2010 Jan; 112(1):239-44. PubMed ID: 20010423 [No Abstract] [Full Text] [Related]
19. DNA polymorphism of the ryanodine receptor gene, exon 17 among six equus species. Ishida N; Hasegawa T; Mukoyama H Anim Genet; 1996 Oct; 27(5):376. PubMed ID: 8930091 [No Abstract] [Full Text] [Related]
20. Screening for mutations in the RYR1 gene in families with malignant hyperthermia. Muniz VP; Silva HC; Tsanaclis AM; Vainzof M J Mol Neurosci; 2003; 21(1):35-42. PubMed ID: 14500992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]